Artal Group’s Alder Biopharmaceuticals ALDR Stock Holding History

Artal Group’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-850,000	Closed	-$10M	–	119
2019 Q2	$10M	Buy	850,000 +350,000	+70%	+$4.24M	0.4%	51
2019 Q1	$6.83M	Buy	500,000 +300,000	+150%	+$3.89M	0.28%	65
2018 Q4	$2.05M	Buy	+200,000	New	+$2.56M	0.08%	94
2018 Q1	–	Sell	-500,000	Closed	-$5.72M	–	144
2017 Q4	$5.72M	Hold	500,000	–	–	0.09%	65
2017 Q3	$6.13M	Buy	500,000 +200,000	+67%	+$2.09M	0.11%	58
2017 Q2	$3.44M	Hold	300,000	–	–	0.06%	78
2017 Q1	$6.24M	Buy	+300,000	New	+$6.64M	0.14%	55

Other funds holding ALDR

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return